Opthea Ltd SEC filings CYVNY
Opthea Ltd has 204 filings in SEC EDGAR's recent list, going back to Jul 17, 2020. Its latest annual report, Form 20-F, was filed on Sep 15, 2025 for the period ended Jun 30, 2025. The most recent current report (Form 6-K) was filed on Nov 20, 2025. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 POS | Filing | Nov 10, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 1, 2022 | — |
| 424B3 | Prospectus | Feb 22, 2021 | — |
| S-8 | Employee stock plan registration | Dec 1, 2020 | — |
| 424B4 | Prospectus | Oct 19, 2020 | — |
| F-1/A | Filing | Oct 15, 2020 | — |
| F-1/A | Filing | Oct 9, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Sep 24, 2020 | — |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CKDXF (OTC), CYVNY (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- South Yarra
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1815620
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.